New postmortem diagnostic biomarker for myocardial infarction: ischemia modified albumin

dc.authorid0000-0002-8552-2005
dc.authorid0000-0002-0526-4457
dc.contributor.authorYagmur, Fatih
dc.contributor.authorCelik, Safa
dc.contributor.authorCemek, Mustafa
dc.contributor.authorHazini, Ahmet
dc.contributor.authorKocaman, A. Tuba
dc.contributor.authorAlpdogtas, Saadet
dc.contributor.authorKonak, H. Busra
dc.date.accessioned2025-05-10T19:44:45Z
dc.date.issued2019
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractWe investigated the change of IMA levels as biochemical markers, especially in the postmortem diagnosis of early MI. Also, histological investigation has been performed in cases of cardiac deaths and in non-cardiac cases. To the best of our knowledge, this is the first study to investigate the levels of IMA in the postmortem diagnosis of early MI. A series of medicolegal autopsy cases (n=139; 6-24 h postmortem, with a median of 16 h) were examined at our institute. The cases comprised 112 males and 27 females, between 16 and 89 years of age. Subjects were divided into six groups depending upon their final cause of death according to medical data, autopsy reports, biochemical and histological findings. The groups were as follows: cardiovascular disease, blunt trauma, asphyxia, pathological cerebral hemorrhage, bleeding due to a sharp object and gunshot injuries, and poisoning. IMA levels in the cardiovascular disease group were found to be significantly higher than the blunt trauma, asphyxia, pathological cerebral hemorrhage, and bleeding groups (p < 0.05). It is known that after MI, if less than 4-6 hours pass before death, the histopathology of the heart does not reveal significant findings. Our results demonstrated that IMA might be a valid biochemical marker, especially in the postmortem diagnosis of early MI.
dc.identifier.doi10.1080/00450618.2017.1340519
dc.identifier.endpage200
dc.identifier.issn0045-0618
dc.identifier.issn1834-562X
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85021267777
dc.identifier.scopusqualityQ2
dc.identifier.startpage191
dc.identifier.urihttps://doi.org/10.1080/00450618.2017.1340519
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11035
dc.identifier.volume51
dc.identifier.wosWOS:000456004700008
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofAustralian Journal of Forensic Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectMyocardial infarction
dc.subjectischemia modified albumin
dc.subjectpostmortem biochemistry
dc.subjectdiagnostic biomarker
dc.subjectforensic pathology
dc.subjectcause of death
dc.titleNew postmortem diagnostic biomarker for myocardial infarction: ischemia modified albumin
dc.typeArticle

Dosyalar